13F filer · CIK 1728001
Athyrium Capital Management, LP
New York, NY · filing since Q4 2017 · last filing Nov 12, 2024
Reported value
$8.7M
$-24.9M vs prior
Positions
2
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $22.2M
Top-10 weight
100.0%
Biggest buys vs Q2 2024
No new or increased positions this quarter.
Biggest sells vs Q2 2024
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | COHERUS BIOSCIENCES INC | -30,000,000 | -100.0% | $-22.2M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2024
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Biora Therapeutics Inc.COM NEW | 10,929,762 | $5.5M | 63.12% |
| 2 | PUMA BIOTECHNOLOGY INCCOM | 1,256,411 | $3.2M | 36.88% |